← Back to Influence Map
Entity DossierOrganization
INCYTE CORPORATION
DE · US
Biopharmaceutical company.
Tracked direct giving
$0
LDA reported lobbying spend
$4,410,000
Connections
6
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MMMMedicare/Medicaid
$8.4MHCRHealth Issues
$1.8MPHAPharmacy
$240KINSInsurance
$120KNATNatural Resources
$120KHOMHousing
$60KGOVGovernment Issues
$60KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$5.3M
TIBER CREEK GROUP$950K
W STRATEGIES, LLC$840K
AVENUE SOLUTIONS$840K
CHECKMATE GOVERNMENT RELATIONS$290K
LMH STRATEGIC SOLUTIONS$240K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | TIBER CREEK GROUP | Hired TIBER CREEK GROUP to lobby on Pharmaceuticals | Source |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing Model | Source |
| Retained | AVENUE SOLUTIONS | Hired AVENUE SOLUTIONS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | W STRATEGIES, LLC | Hired W STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | LMH STRATEGIC SOLUTIONS | Hired LMH STRATEGIC SOLUTIONS to lobby (3rd Quarter (July 1 - Sep 30) 2025) | Source |
| Retained | CHECKMATE GOVERNMENT RELATIONS | Hired CHECKMATE GOVERNMENT RELATIONS to lobby (4th Quarter (Oct 1 - Dec 31) 2025) | Source |